Therapy-related leukemia and myelodysplastic syndrome.
Kantarjian
H M
HM
Department of Hematology, University of Texas, M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Keating
M J
MJ
D000970:Antineoplastic Agents / Q000009:adverse effects*; D004198:Disease Susceptibility; D007938:Leukemia / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects
D000970:Antineoplastic Agents